Neurontin (Gabapentin)

Gabapentin binds to the α2δ subunit of voltage‑gated calcium channels in the central nervous system. This binding limits calcium entry into neurons, which in turn decreases the release of excitatory neurotransmitters such as glutamate and substance P, dampening neuronal hyper‑excitability that contributes to seizures and neuropathic pain.

The appropriate dose of Neurontin is individualized by the prescribing clinician based on the specific indication, patient age, renal function and treatment response. Dosage may be started low and titrated upward, but exact amounts should only be determined by a qualified healthcare professional.

Safety data for gabapentin during pregnancy and lactation are limited. It should only be used when the potential therapeutic benefit outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To place an order, submit an enquiry on the Neurontin product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

The primary alternative to gabapentin is pregabalin, another α2δ‑ligand anticonvulsant. Both share a similar mechanism, but pregabalin often has higher bioavailability and may achieve therapeutic effect at lower doses. Individual response, tolerability, cost and specific regulatory approvals guide the choice between the two agents.

Neurontin should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid environments such as bathrooms.

Neurontin is taken orally, usually with a glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal discomfort for some patients. Tablets should be swallowed whole and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious risks include suicidal thoughts or behavior, severe allergic reactions such as Stevens‑Johnson syndrome, respiratory depression (especially when combined with other depressants), angioedema, and rare blood disorders. Patients should seek immediate medical attention if they experience mood changes, rash, swelling of the face or throat, or unexplained bleeding.

Neurontin is contraindicated in patients with known hypersensitivity to gabapentin or any of the tablet excipients. Caution is advised for individuals with severe renal impairment, uncontrolled psychiatric illness, or those taking multiple central nervous system depressants. Pregnant or breastfeeding women should only use it under strict medical supervision.